Assembly Biosciences, Inc.
ASMB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $138,724 | $71,760 | $103,850 |
| - Cash | $22,534 | $24,006 | $23,413 | $38,344 |
| + Debt | $2,207 | $2,884 | $3,020 | $3,089 |
| Enterprise Value | – | $117,602 | $51,367 | $68,595 |
| Revenue | $10,789 | $9,626 | $9,419 | $7,357 |
| % Growth | 12.1% | 2.2% | 28% | – |
| Gross Profit | $10,789 | -$6,499 | $9,419 | -$6,923 |
| % Margin | 100% | -67.5% | 100% | -94.1% |
| EBITDA | -$9,164 | -$11,061 | -$9,908 | -$11,500 |
| % Margin | -84.9% | -114.9% | -105.2% | -156.3% |
| Net Income | -$9,196 | -$10,198 | -$8,818 | -$10,335 |
| % Margin | -85.2% | -105.9% | -93.6% | -140.5% |
| EPS Diluted | -1.2 | -1.33 | -1.17 | -1.72 |
| % Growth | 9.8% | -13.7% | 32% | – |
| Operating Cash Flow | -$15,133 | -$16,758 | -$23,439 | -$407 |
| Capital Expenditures | -$42 | $0 | $0 | $0 |
| Free Cash Flow | -$15,175 | -$16,758 | -$23,439 | -$407 |